Patients who are uninsured may be eligible to receive YUFLYMA® (adalimumab-aaty) at no cost. Patient eligibility criteria, including household income limits, and program
terms and conditions apply*. Celltrion CONNECT can help evaluate patients’ eligibility for assistance.
To enroll in PAP,
download and fax the PAP enrollment application to
614-633-2259.
